NCT02408393View on ClinicalTrials.gov

MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

March 27, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

March 9, 2019

Conditions
Malignant Neoplasm of Breast
Interventions
DRUG

Saline

DRUG

Ropivacaine

Trial Locations (6)

54511

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

63011

Centre Jean PERRIN, Clermont-Ferrand

69008

Centre Léon Bérard, Lyon

75005

INSTITUT CURIE - Site Paris, Paris

92210

Institut Curie site Saint-Cloud, Saint-Cloud

06189 NICE Cedex

Centre Antoine LACASSAGNE, Nice

All Listed Sponsors
lead

Institut Curie

OTHER

NCT02408393 - MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery | Biotech Hunter | Biotech Hunter